It found that 75 per cent of patients saw a significant decrease in their self-reported illness severity.
Medical cannabis can play an efficient role in managing fibromyalgia and its associated symptoms such as depression and anxiety according to a new study by MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ).
The study was published in the American Journal of Endocannabinoid Medicine and was run by MediPharm Labs wholly-owned subsidiary, Harvest Medicine. It found that 75 per cent of patients saw a significant decrease in their self-reported illness severity. Anxiety scores improved in 22 per cent with mild-moderate severity and 48 per cent in those with severe anxiety.
– Read the entire article at Mugglehead Magazine.
Original Article
